MAVIS Hub Edition 122
Published 3 May 2022
1. Enforcement
Animal medicine seizure notice: Parcel addressed to premises in Dunadry, Antrim
Animal medicine improvement notice: Swinfen Veterinary Centre, Staffordshire
Animal medicine seizure notice: Parcel addressed to premises in Belfast
2. AMR (Antimicrobial Resistance)
2.1 Defra Antimicrobial Resistance Co-ordination (DARC) group
The DARC group met virtually on 3 March 2022 to discuss the recent findings on AMR in bacteria of importance to animal and public health. The meeting included presentations on companion animal and equine stewardship from both RCVS Knowledge and RUMA Companion Animal and Equine Alliance. Minutes from the previous meetings
2.2 Policy and communications update
Policy priorities for this year include:
- continued implementation of animal health-specific aspects of the cross-government UK AMR National Action Plan (2019 to 2024)
- continued work to pursue the AMR commitments made in 2021 during the UK’s G7 Presidency, in support of Germany’s 2022 G7 Presidency
- finishing touches to a Case Study report written by the VMD and stakeholders detailing the UK’s reduction in sales and use of antibiotics for food-producing animals. The report will be published by the Food and Agriculture Organisation of the United Nations and highlight the value of the multi-sectoral voluntary collaborative approach adopted in the UK.
During February the VMD ran a mini social media campaign to support the Agriculture and Horticulture Development Board’s (AHDB) ColostrumIsGold campaign. Tweets included tips on colostrum management to promote neonatal health and reduce the need of antibiotics, and links to AHDB’s resources.
3. Inspections
During the period from 1 January 22 to 31 March 22 the Distribution and Supply Chain Inspection Section carried out a total of 297 inspections of retail and feed business premises to assess their compliance with the Veterinary Medicines Regulations 2013. We have restarted on-site inspections, however, due to the ongoing pandemic we are still carrying out some remote assessments where we believe they are appropriate.
3.1 Retail Premises
We inspected 235 retail premises (veterinary practice premises and SQP retailers) and the compliance ratings for these inspections were as follows (5 being the highest, 1 being the lowest):
Rating | No. of premises | Percentage |
---|---|---|
5 | 102 | 43% |
4 | 100 | 43% |
3 | 29 | 12% |
2 | 0 | 0% |
1 | 4 | 2% |
The most common deficiencies that required corrective action, which were all observed in veterinary practice premises, were:
- Broach dates exceeded or not recorded
- Controlled Drug (CD) Registers not maintained as required
- Issues with the annual audit of Prescription Only Medicines
The requirements for retailers are published on Gov.UK
3.2 Feed Business Operator premises
We inspected 62 Feed Business Operator (FeBO) premises and the compliance ratings for these inspections were as follows (5 being the highest, 1 being the lowest):
Rating | No. of premises | Percentage |
---|---|---|
5 | 25 | 40% |
4 | 30 | 48% |
3 | 6 | 10% |
2 | 1 | 2% |
1 | 0 | 0% |
The most common deficiencies that required corrective action were:
- HACCP plan not documented/implemented/maintained as required
- Hygiene issues
- Labelling issues
- The absence of or unsatisfactory complaints/recall procedure
The requirements for Feed Business Operator (FeBO) premises are published on Gov.UK)
4. Guidance Updates
United Kingdom-New Zealand Regulatory Cooperation: Guidance on Veterinary Drug Simultaneous Reviews
Controlled drugs: recording, using, storing and disposal
VMD temporary enforcement policy under specific COVID‐19 circumstances
Marketing Authorisations for Parallel Import of veterinary medicines
Veterinary medicine wholesale dealer’s authorisation (WDA)
Apply for batch release of an immunological veterinary medicine
Autogenous Vaccine, Non-Food Animal Blood Bank, Equine Stem Cell Centre Authorisation
5. Research and statistics
VMD Published Standards 2021 to 2022: Monitoring performance
Top ten imported veterinary medicines - Quarterly report 1 January 2022 and 31 March 2022
6. Stakeholder engagement
United Kingdom – New Zealand Regulatory Cooperation